|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gompelmann D, Eberhardt R and Herth FJ:
Advanced malignant lung disease: What the specialist can offer.
Respiration. 82:111–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang M, Shi J, Peng N and He S:
MicroRNA-211 promotes non-small-cell lung cancer proliferation and
invasion by targeting MxA. Onco Targets Ther. 10:5667–5675. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mallory AC and Vaucheret H: MicroRNAs:
Something important between the genes. Curr Opin Plant Biol.
7:120–125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Florczuk M, Szpechcinski A and
Chorostowska-Wynimko J: miRNAs as biomarkers and therapeutic
targets in non-small cell lung cancer: Current perspectives. Target
Oncol. 12:179–200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saleiban A, Faxälv L, Claesson K, Jönsson
JI and Osman A: miR-20b regulates expression of
proteinase-activated receptor-1 (PAR-1) thrombin receptor in
melanoma cells. Pigment Cell Melanoma Res. 27:431–441. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Chen D, Jin L, Liu J, Su Z, Li Y,
Gui Y and Lai Y: MicroRNA-20b-5p functions as a tumor suppressor in
renal cell carcinoma by regulating cellular proliferation,
migration and apoptosis. Mol Med Rep. 13:1895–1901. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li M, Zhou Y, Xia T, Zhou X, Huang Z,
Zhang H, Zhu W, Ding Q and Wang S: Circulating microRNAs from the
miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers
for breast cancer. Breast Cancer Res Treat. 170:257–270. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leidinger P, Brefort T, Backes C, Krapp M,
Galata V, Beier M, Kohlhaas J, Huwer H, Meese E and Keller A:
High-throughput qRT-PCR validation of blood microRNAs in non-small
cell lung cancer. Oncotarget. 7:4611–4623. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Greene FL, Page DL, Fleming ID, Fritz A,
Balch CM and Haller DG: AJCC cancer staging handbook from the AJCC
cancer staging manual. (6th). Springer. (New York). 2002.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao X, Zhao H, Diao C, Wang X, Xie Y, Liu
Y, Han J and Zhang M: miR-455-3p serves as prognostic factor and
regulates the proliferation and migration of non-small cell lung
cancer through targeting HOXB5. Biochem Biophys Res Commun.
495:1074–1080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanzer A and Stadler PF: Molecular
evolution of a microRNA cluster. J Mol Biol. 339:327–335. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17-92, is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Landais S, Landry S, Legault P and Rassart
E: Oncogenic potential of the miR-106-363 cluster and its
implication in human T-cell leukemia. Cancer Res. 67:5699–5707.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng YC, Lin TY and Shieh SY: Candidate
tumor suppressor BTG3 maintains genomic stability by promoting
Lys63-linked ubiquitination and activation of the checkpoint kinase
CHK1. Proc Natl Acad Sci USA. 110:5993–5998. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Majid S, Dar AA, Ahmad AE, Hirata H,
Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G and
Dahiya R: BTG3 tumor suppressor gene promoter demethylation,
histone modification and cell cycle arrest by genistein in renal
cancer. Carcinogenesis. 30:662–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lv C, Wang H, Tong Y, Yin H, Wang D, Yan
Z, Liang Y, Wu D and Su Q: The function of BTG3 in colorectal
cancer cells and its possible signaling pathway. J Cancer Res Clin
Oncol. 144:295–308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
An Q, Zhou Y, Han C, Zhou Y, Li F and Li
D: BTG3 overexpression suppresses the proliferation and invasion in
epithelial ovarian cancer cell by regulating AKT/GSK3β/β-catenin
signaling. Reprod Sci. 24:1462–1468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X, Chen G, Cao X, Zhou Y, Yang T and
Wei S: Downregulation of BTG3 in non-small cell lung cancer.
Biochem Biophys Res Commun. 437:173–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo J, Xiao ZW, Yu XW and Cao RF: miR-20b
promotes cellular proliferation and migration by directly
regulating phosphatase and tensin homolog in prostate cancer. Oncol
Lett. 14:6895–6900. 2017.PubMed/NCBI
|
|
27
|
Luo W, Li G, Yi Z, Nie Q and Zhang X:
E2F1-miR-20a-5p/20b-5p auto-regulatory feedback loop involved in
myoblast proliferation and differentiation. Sci Rep. 6:279042016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY
and Shieh SY: The candidate tumor suppressor BTG3 is a
transcriptional target of p53 that inhibits E2F1. EMBO J.
26:3968–3980. 2007. View Article : Google Scholar : PubMed/NCBI
|
